CD8A and cerebral malaria: Recently it was also shown that the activation of pathogenic CD8+ T cell responses in the course of cerebral malaria are dependent on glutamine metabolism and in vivo administration of DON in the late-phase of experimental cerebral malaria was able to inhibit the pathogenic CD8+ T cells responses thus rescuing the clinical manifestation signs of disease (Gordon et al., 2015).